๐€๐ง๐ญ๐ข๐ฌ๐ž๐ง๐ฌ๐ž ๐Ž๐ฅ๐ข๐ ๐จ๐ง๐ฎ๐œ๐ฅ๐ž๐จ๐ญ๐ข๐๐ž๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ, ๐ˆ๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ, ๐…๐จ๐ซ๐ž๐œ๐š๐ฌ๐ญ ๐›๐ฒ 2024-2032 | ๐‘๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ ๐š๐ง๐ ๐ˆ๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ

๐‘๐ž๐š๐ ๐ฆ๐จ๐ซ๐ž: https://www.reportsandinsights.....com/report/antisens

Business

The global antisense oligonucleotides market size reached US$ 2.8 billion in 2023. The market to reach US$ 4.9 billion in 2032, exhibiting a growth rate (CAGR) of 6.5% during 2024-2032.